Jayex Technology Past Earnings Performance
Past criteria checks 0/6
Jayex Technology's earnings have been declining at an average annual rate of -38.9%, while the Healthcare Services industry saw earnings growing at 15.2% annually. Revenues have been declining at an average rate of 13.6% per year.
Key information
-38.9%
Earnings growth rate
-30.1%
EPS growth rate
| Healthcare Services Industry Growth | 42.6% |
| Revenue growth rate | -13.6% |
| Return on equity | n/a |
| Net Margin | -105.5% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Revenue & Expenses BreakdownBeta
How Jayex Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 4 | -4 | 2 | 0 |
| 30 Sep 23 | 4 | -5 | 2 | 0 |
| 30 Jun 23 | 4 | -6 | 2 | 0 |
| 31 Mar 23 | 4 | -6 | 2 | 0 |
| 31 Dec 22 | 5 | -6 | 2 | 0 |
| 30 Sep 22 | 5 | -5 | 2 | 0 |
| 30 Jun 22 | 5 | -3 | 2 | 0 |
| 31 Mar 22 | 5 | -4 | 2 | 0 |
| 31 Dec 21 | 5 | -4 | 2 | 0 |
| 30 Sep 21 | 4 | -3 | 2 | 0 |
| 30 Jun 21 | 4 | -3 | 1 | 0 |
| 31 Mar 21 | 5 | -2 | 2 | 0 |
| 31 Dec 20 | 6 | -1 | 2 | 0 |
| 30 Sep 20 | 6 | -1 | 1 | 0 |
| 30 Jun 20 | 7 | 0 | 1 | 0 |
| 31 Mar 20 | 7 | -1 | 1 | 0 |
| 31 Dec 19 | 7 | -1 | 1 | 0 |
| 30 Sep 19 | 7 | -1 | 1 | 0 |
| 30 Jun 19 | 7 | -1 | 2 | 0 |
| 31 Mar 19 | 7 | -1 | 2 | 0 |
| 31 Dec 18 | 7 | -1 | 2 | 0 |
| 30 Sep 18 | 7 | -1 | 2 | 0 |
| 30 Jun 18 | 7 | -1 | 2 | 0 |
| 31 Mar 18 | 7 | -2 | 2 | 0 |
| 31 Dec 17 | 8 | -2 | 2 | 0 |
| 30 Sep 17 | 7 | -4 | 2 | 0 |
| 30 Jun 17 | 7 | -5 | 2 | 0 |
| 31 Mar 17 | 8 | -5 | 2 | 0 |
| 31 Dec 16 | 9 | -5 | 2 | 0 |
| 30 Jun 16 | 7 | -4 | 2 | 0 |
| 31 Mar 16 | 4 | -4 | 1 | 0 |
| 31 Dec 15 | 2 | -3 | 1 | 0 |
| 30 Jun 15 | 1 | -1 | 1 | 0 |
| 30 Jun 14 | 0 | 0 | 0 | 0 |
Quality Earnings: JTL is currently unprofitable.
Growing Profit Margin: JTL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: JTL is unprofitable, and losses have increased over the past 5 years at a rate of 38.9% per year.
Accelerating Growth: Unable to compare JTL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: JTL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (13.5%).
Return on Equity
High ROE: JTL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.